Strides Pharma Science Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Strides Pharma Science Limited generated cash of $7,010,650,000, which is more than the previous year. Cash used in financing activities reached the amount of -$6,933,230,000 last year. Net change in cash is therefore -$1,424,810,000.
Cash Flow
| 2010 | 3.23B | -9.40B | 8.50B |
|---|---|---|---|
| 2011 | 4.57B | -6.56B | 893.61M |
| 2012 | 1.34B | 8.06B | -9.90B |
| 2016 | 716.57M | -22.28B | 29.48B |
| 2018 | 1.87B | 5.82B | -10.15B |
| 2020 | 2.04B | 13.06B | -17.09B |
| 2021 | 4.81B | -5.20B | -157.96M |
| 2023 | 444.11M | 3.02B | -2.13B |
| 2024 | 7.01B | -1.50B | -6.93B |
STAR.NS Cash Flow Statement (2010 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | 2013 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 3.03B | 1.70B | 1.82B | 3.65B | 5.15B | 2.98B | 2.12B | 3.25B | 787.85M |
Operating activities | |||||||||
Net income | -627.24M | -2.67B | 2.89B | 485.08M | 7.05B | 2.67B | 9.49B | 2.24B | 1.22B |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 2.20B | 2.43B | 2.06B | 1.87B | 1.93B | 1.57B | 1.09B | 1.04B | 638.54M |
Stock-based compensation expense | 15.86M | 13.01M | 68.02M | 17.53M | 24.52M | 11.73M | 0 | 0 | 0 |
| Deferred income tax benefit | 15.86M | 13.01M | 68.02M | 17.53M | 24.52M | 11.73M | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | 390.9M | -3.47B | -1.24B | -1.59B | -2.74B | -4.52B | 0 | 0 | 0 |
Inventories | 307.04M | -81.38M | -4.14B | -1.62B | 840.86M | -1.67B | -1.05B | -1.35B | -839.48M |
Accounts payable | -1.48B | -1.02B | 2.10B | -45.99M | -4.96M | 2.77B | 0 | 0 | 0 |
Cash generated by operating activities | 7.01B | 444.11M | 4.81B | 2.04B | 1.87B | 716.57M | 1.34B | 4.57B | 3.23B |
Investing activities | |||||||||
Purchases Of Investments | -783.98M | -1.57B | -2.77B | -1.10B | -3.00B | -4.39B | -187.56M | -4.42B | -8.01B |
Investments In Property Plant And Equipment | -1.18B | -949.38M | -2.97B | -1.50B | -4.02B | -22.95B | -3.37B | -2.39B | -1.66B |
Acquisitions Net | 7.91M | 5.19B | -78.86M | -272.26M | -2.38B | 573.13M | 0 | 0 | 0 |
Cash generated by investing activities | -1.50B | 3.02B | -5.20B | 13.06B | 5.82B | -22.28B | 8.06B | -6.56B | -9.40B |
Financing activities | |||||||||
Common Stock Issued | 526.74M | 384.67M | 34.99M | 4.8M | 36.31M | 11.64B | 88.66M | 72.45M | 5.03B |
Payments for dividends | -135.17M | 0 | -179.15M | -1.53B | -442.86M | -246.1M | -136.47M | -100.71M | -75.86M |
Repurchases of common stock | 0 | 0 | 3.90B | 0 | 0 | 0 | -539.49M | 0 | -325.75M |
Repayments of term debt | -3.84B | 249.28M | -3.92B | -13.49B | -7.11B | 19.11B | -10.01B | -3.69B | -2.26B |
Cash used in financing activities | -6.93B | -2.13B | -157.96M | -17.09B | -10.15B | 29.48B | -9.90B | 893.61M | 8.50B |
Net Change In Cash | -1.42B | 1.32B | -564M | -1.83B | -2.58B | 8.10B | -798.02M | -1.12B | 2.46B |
Cash at end of period | 1.61B | 3.03B | 1.25B | 1.82B | 2.56B | 11.08B | 1.32B | 2.12B | 3.24B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |